Herpes Simplex Virus Primarily by Linda Wallen, MD Edited May, 2005.
-
Upload
curtis-pitts -
Category
Documents
-
view
215 -
download
1
Transcript of Herpes Simplex Virus Primarily by Linda Wallen, MD Edited May, 2005.
Herpes Simplex Virus
Primarily by Linda Wallen, MDEdited May, 2005
Epidemiology of Herpes Simplex
• 5 % patients have a history of HSV • > 20% have serologic evidence of HSV
Primary infection = Patient has NO antibodies to HSV Nonprimary= prior exposure to either HSV-1 or HSV-2 Recurrent infection = + antibodies to reactivating
virus type Shedding at delivery not predicted from past cultures
• > 2/3 of babies with HSV infection are born to mothers with NO previous history of HSV
• Risk neonatal infection with recurrence= 2-5%• Risk neonatal infection with primary inf.= 35%
Pathway of Infection for Neonatal HSV
Pathway of Infection for Neonatal HSV
• < 5% with intrauterine acquired infection• Primary infection may be associated with a
higher risk of spontaneous abortion, preterm delivery, and neonatal infection Higher viral load, longer excretion (14-21 days) No transplacental antibody
• 85% cases are acquired at the time of delivery Risk increased with PROM (> 6 hour), application of
fetal scalp electrodes and other invasive tests
• 10% acquired postnatally
Presentation of Neonatal HSV Infection
Presentation of Neonatal HSV Infection
• > 90% present between 5-19 days of age• > 20% NEVER have skin lesions• Initial symptoms vague in 30%
LethargyPoor feedingFever Irritability
• Intrauterine acquisition: skin lesions, scars, chorioretinitis, evidence of CNS involvement (hydranencephaly or microcephaly)
Onset of Neonatal HSV InfectionOnset of Neonatal HSV Infection
0
5
10
15
20
25O
nset
of
sym
pto
ms (
day)
*
Disse
min
ated
SEMCNS
HSV
type 1
HSV
type 2
Acta Paediatr 84:256, 1995
Signs & Symptoms of Neonatal HSV Before Treatment
Signs & Symptoms of Neonatal HSV Before Treatment
Disseminated Encephalitis Skin/eye/mouth Skin vesicles (%) (# d+SEM)
58 4 +1
63 6 +1
83 4 +1
Lethargy (%) (# d+SEM)
47 3 +1
49 5 +1
19
Fever (%) (# d+SEM)
56 5 +1
44 3 +1
17 5 +1
Conjunctiv (%) (# d+SEM)
17 6 +2
16 4 +1
25 6 +2
Seizures (%) (# d+SEM)
22 2 +1
57 3 +1
2 7
Pneumonia (%) (# d+SEM)
37 4 +1
3 9+6
0
Pediatrics 108 (2): 226, 2001
Diagnosis of Neonatal HSV Infection
Diagnosis of Neonatal HSV Infection
Gold standard = Positive culture of: lesion, nasopharynx, conjunctiva, rectum, or CSF
• Rapid diagnostic methods Polymerase chain reaction on CSF and
blood Fluorescent antibody stain on vesicle
scraping
Treatment of Neonatal HSVTreatment of Neonatal HSV
• Acyclovir 60 mg/kg/day IV given q8h Suspect infection - 2 d of negative
cultures Definite infection - 14 d for SEM, 21
d CNS
• Topical ocular ointment for eye lesions
Mortality & Morbidity after 1 Year of Age: 1981-1997Mortality & Morbidity after 1 Year of Age: 1981-1997
0
20
40
60
80
100
CNS Dissemin CNS Dissemin
HSV-1
HSV-2
Mortality Severe DisabilityPediatrics 108 (2): 227, 2001
Peripartum Management of Pregnant Women with History of
HSV
Peripartum Management of Pregnant Women with History of
HSV• If no active lesions, normal vaginal delivery• No current recommendation to culture for mother
or infant for HSV•Options with active lesions at onset of labor:
If term and ROM <4-6 (?24) hours, C-section If preterm and ROM, may manage expectantly with or without acyclovir, betamethasone treatment, etc. OR may offer C-section
• C-section does NOT eliminate risk of neonatal HSV
Peripartum Management of Pregnant Women with Possible Primary HSV
• Viral culture of active lesions• Serological classification if accurate testing
available• Value of acyclovir is not known• If 3rd trimester, consider weekly cultures
• primary infection associated with prolonged viral shedding
• If preterm and ROM, may manage expectantly +/- acyclovir, betamethasone treatment, etc.• OR may offer C-section
• Viral culture of active lesions• Serological classification if accurate testing
available• Value of acyclovir is not known• If 3rd trimester, consider weekly cultures
• primary infection associated with prolonged viral shedding
• If preterm and ROM, may manage expectantly +/- acyclovir, betamethasone treatment, etc.• OR may offer C-section
Management of the Asymptomatic Neonate Exposed
to HSV at Delivery
Management of the Asymptomatic Neonate Exposed
to HSV at Delivery• For recurrent maternal HSV:
Separate from other newborns, may stay with mom in private room
Instruct parents re: subtle signs infection, skin lesions
Obtain cultures at 24-48 hours from vesicles, nasopharynx, conjunctiva, and rectum (do not pool rectal cultures with other cultures)
If cultures are positive then treat with acyclovir Delay circumcision for > 1 month
Management of the Asymptomatic Neonate Exposed
to HSV at Delivery
Management of the Asymptomatic Neonate Exposed
to HSV at Delivery• For first episode genital infection:
Manage with contact precautions (gown, glove), isolation
Obtain cultures from vesicles, nasopharynx, conjunctiva, and rectum (do not pool rectal cultures with other cultures)
Lumbar puncture for HSV PCR and culture Treat with acyclovir Delay circumcision for > 1 month